NCT04412798Completed
Orange Juice and Glycaemic Control in Type 2 Diabetes Mellitus
Impact of Orange Juice During Breakfast on Glycaemic Control in Individuals With Type 2 Diabetes Mellitus
Source: ClinicalTrials.gov · Last updated 17 May 2024
Brief summary (registry, in English)
The evidence on the consumption of 100% orange juice in people with type 2 diabetes is highly variable and largely out-of-date, with a few studies reporting acute negative glycaemic effects when 100% orange juice is drunk with or without a meal. The aim of the project is to study the impact of the intake of a single serving of 100% orange juice on glycaemic control in male patients with pre-existing type 2 diabetes mellitus. In addition, immunological parameters and Alzheimer disease related biomarkers will be assessed to examine the chronic inflammatory state of these patients
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 15 (actual)
- First submitted
- 29 May 2020
- Start date
- 1 May 2020
- Primary completion date
- 1 Apr 2024
- Lead sponsor
- Hasselt University
- Diseases
- Type 2 diabetes
- NCT number
- NCT04412798
What you commit to
- Study type: Interventional
- Participants enrolled: 15
- From 1 May 2020 to the primary completion date, 1 Apr 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- participants on exogenous insulin therapy,
Other illness
- participants with established cardiovascular disease,
- neurological disease,
- cancer,
- renal disease.
Lab values
- HbA1c \>8.5%,
Other
- pregnancy,
- BMI \<22 or \>35 kg/m²,
- regular smokers (\>1 cigarette per day),
- Participants who are unwilling to consume any of the standard foods/drinks
Who the study is looking for
- Inclusion Criteria: individuals (aged 25-75 years) with up to 8 years of T2DM, according to ADA criteria (Two-hour plasma glucose ≥200 mg/dL (11.1 mmol/L) during OGTT. The test should be performed as described by the WHO, using a glucose load containing the equivalent of 75-g anhydrous glucose dissolved in water; or HbA1c \> ≥6.5% (48 mmol/mol)).
Age in the registry: 25 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hasselt University Coordinator of this site? Confirm its status | Hasselt | Belgium | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.